Warby Parker (WRBY) Receives a Hold from UBS
UBS analyst Mark Carden maintained a Hold rating on Warby Parker today and set a price target of $25.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Carden is a 4-star analyst with an average return of 16.1% and a 77.63% success rate. Carden covers the Consumer Defensive sector, focusing on stocks such as Ollie’s Bargain Outlet Holding, Dollarama, and Sysco.
In addition to UBS, Warby Parker also received a Hold from TipRanks – OpenAI’s OpenAI Medical – Instruments and Supplies in a report issued today. However, on the same day, TD Cowen reiterated a Buy rating on Warby Parker (NYSE: WRBY).
Based on Warby Parker’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $221.68 million and a net profit of $5.87 million. In comparison, last year the company earned a revenue of $192.45 million and had a GAAP net loss of $4.07 million
Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of WRBY in relation to earlier this year. Most recently, in December 2025, Joel Cutler, a Director at WRBY sold 19,932.00 shares for a total of $518,431.32.
Read More on WRBY:
Disclaimer & DisclosureReport an Issue
- Warby Parker: Accelerated Growth, AI-Driven Product Expansion, and Path to Profitability Support Raised Buy Rating
- AI Daily: Nvidia under pressure despite blowout earnings
- Warby Parker rises 21.7%
- Warby Parker says to introduce first AI glasses in partnership with Google, Samsung
- Warby Parker: Conservative Reset Today, Underappreciated Smart‑Glasses Upside Tomorrow
